{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:15:12Z","timestamp":1788628512841,"version":"build-2803163510"},"reference-count":63,"publisher":"Scientific Scholar","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Orthopaedics"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jor.2019.05.006","type":"journal-article","created":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T10:43:51Z","timestamp":1558781031000},"page":"522-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analogs of C-type natriuretic peptide as a potential new non-surgical treatment strategy in knee osteoarthritis"],"prefix":"10.25259","volume":"16","author":[{"given":"Ahmet Cevik","family":"Tufan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"issue":"3","key":"10.1016\/j.jor.2019.05.006_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1517\/14728214.2015.1037275","article-title":"Emerging drugs for the treatment of knee osteoarthritis","volume":"20","author":"Yu","year":"2015","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.jor.2019.05.006_bib2","article-title":"Non-surgical management of knee osteoarthritis: where are we now and where do we need to go?","volume":"1","author":"Buttgereit","year":"2014","journal-title":"RMD Open"},{"issue":"R1","key":"10.1016\/j.jor.2019.05.006_bib3","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1093\/hmg\/ddv419","article-title":"Advances in treatment of achondroplasia and osteoarthritis","volume":"25","author":"Klag","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.jor.2019.05.006_bib4","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1186\/ar3459","article-title":"Biomechanical signals and the C-type natriuretic peptide counteract catabolic activities induced by IL1\u03b2 in chondrocyte\/agarose constructs","volume":"13","author":"Ramachandran","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.jor.2019.05.006_bib5","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/ar4253","article-title":"Natriuretic peptide receptors regulate cytoprotective effects in a human ex vivo 3D\/bioreactor model","volume":"15","author":"Peake","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.jor.2019.05.006_bib6","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.joca.2014.07.018","article-title":"Role of C-type natriuretic peptide signalling in maintaining cartilage and bone function","volume":"22","author":"Peake","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"10.1016\/j.jor.2019.05.006_bib7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bbrc.2015.08.087","article-title":"C-type natriuretic peptide signalling drives homeostatic effects in human chondrocytes","volume":"465","author":"Peake","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.jor.2019.05.006_bib8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1021\/bm501575w","article-title":"Controlled release of C-type natriuretic peptide by microencapsulation dampens proinflammatory effects induced by IL-1\u03b2 in cartilage explants","volume":"16","author":"Peake","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jor.2019.05.006_bib9","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2106\/00004623-201310160-00010","article-title":"The American Academy of Orthopaedic Surgeons evidence-based guideline on: treatment of osteoarthritis of the knee","volume":"95","author":"Jevsevar","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jor.2019.05.006_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.21596","article-title":"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee","volume":"64","author":"Hochberg","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jor.2019.05.006_bib11","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/annrheumdis-2012-202745","article-title":"EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis","volume":"72","author":"Fernandes","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jor.2019.05.006_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semarthrit.2014.05.014","article-title":"An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)","volume":"44","author":"Bruyere","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jor.2019.05.006_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","article-title":"OARSI guidelines for the non-surgical management of knee osteoarthritis","volume":"22","author":"McAlindon","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"10.1016\/j.jor.2019.05.006_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/BOR.0000000000000351","article-title":"Recent developments in emerging therapeutic targets of osteoarthritis","volume":"29","author":"Sun","year":"2017","journal-title":"Curr Opin Rheumatol"},{"issue":"15","key":"10.1016\/j.jor.2019.05.006_bib15","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1080\/14656566.2016.1232396","article-title":"Intra-articular therapies for osteoarthritis","volume":"17","author":"Yu","year":"2016","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl 3","key":"10.1016\/j.jor.2019.05.006_bib16","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.joca.2010.05.027","article-title":"Recommendations for the use of preclinical models in the study and treatment of osteoarthritis","volume":"18","author":"Poole","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.jor.2019.05.006_bib17","first-page":"1428","article-title":"Bioactivity and metabolism of C-type natriuretic peptide in normal man","volume":"78","author":"Hunt","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.jor.2019.05.006_bib18","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1742-4658.2011.08082.x","article-title":"Natriuretic peptide metabolism, clearance and degradation","volume":"278","author":"Potter","year":"2011","journal-title":"FEBS J"},{"issue":"6","key":"10.1016\/j.jor.2019.05.006_bib19","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.10.014","article-title":"Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia","volume":"91","author":"Lorget","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.jor.2019.05.006_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1124\/jpet.114.218560","article-title":"Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism","volume":"353","author":"Wendt","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jor.2019.05.006_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000439334","article-title":"C-type natriuretic peptide analog as therapy for achondroplasia","volume":"30","author":"Legeai-Mallet","year":"2016","journal-title":"Endocr Dev"},{"key":"10.1016\/j.jor.2019.05.006_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/er.2005-0014","article-title":"Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions","volume":"27","author":"Potter","year":"2006","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.jor.2019.05.006_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2217\/bmm.10.67","article-title":"C-type natriuretic-derived peptides as biomarkers in human disease","volume":"4","author":"Lippert","year":"2010","journal-title":"Biomark Med"},{"issue":"4-5","key":"10.1016\/j.jor.2019.05.006_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10735-010-9284-4","article-title":"Dose dependent effect of C-type natriuretic peptide signaling in glycosaminoglycan synthesis during TGF-\u03b21 induced chondrogenic differentiation of mesenchymal stem cells","volume":"41","author":"Tezcan","year":"2010","journal-title":"J Mol Histol"},{"issue":"1","key":"10.1016\/j.jor.2019.05.006_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1086\/301917","article-title":"Acromesomelic dysplasia Maroteaux type maps to human chromosome 9","volume":"63","author":"Kant","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.jor.2019.05.006_bib26","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1034\/j.1399-0004.2000.570406.x","article-title":"Localization of an acromesomelic dysplasia on chromosome 9 by homozygosity mapping","volume":"57","author":"Ianakiev","year":"2000","journal-title":"Clin Genet"},{"issue":"Suppl A","key":"10.1016\/j.jor.2019.05.006_bib27","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.ghir.2006.03.016","article-title":"C-type natriuretic peptide in growth: a new paradigm","volume":"16","author":"Olney","year":"2006","journal-title":"Growth Horm IGF Res"},{"issue":"1","key":"10.1016\/j.jor.2019.05.006_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1086\/422013","article-title":"Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux","volume":"75","author":"Bartels","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jor.2019.05.006_bib29","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1210\/jc.2005-1949","article-title":"Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature","volume":"91","author":"Olney","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"42","key":"10.1016\/j.jor.2019.05.006_bib30","first-page":"1839","article-title":"Acromesomelic dwarfism","volume":"79","author":"Maroteaux","year":"1971","journal-title":"Presse Med"},{"key":"10.1016\/j.jor.2019.05.006_bib31","doi-asserted-by":"crossref","first-page":"10729","DOI":"10.1016\/S0021-9258(17)34119-4","article-title":"Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B","volume":"269","author":"Hagiwara","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jor.2019.05.006_bib32","doi-asserted-by":"crossref","first-page":"11695","DOI":"10.1074\/jbc.273.19.11695","article-title":"Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide\/guanylyl cyclase-B pathway","volume":"273","author":"Yasoda","year":"1998","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.jor.2019.05.006_bib33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1203\/00006450-200002000-00007","article-title":"Regulation of fetal rat bone growth by C-type natriuretic peptide and cGMP","volume":"47","author":"Mericq","year":"2000","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jor.2019.05.006_bib34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s007740200019","article-title":"C-type natriuretic peptide\/guanylate cyclase B system in ATDC5 cells, a chondrogenic cell line","volume":"20","author":"Suda","year":"2002","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jor.2019.05.006_bib35","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/humu.20511","article-title":"Overexpression of the Ctype natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation","volume":"28","author":"Bocciardi","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jor.2019.05.006_bib36","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/humu.20611","article-title":"A cluster of translocation breakpoints in 2q37 is associated with overexpression of NPPC in patients with a similar overgrowth phenotype","volume":"28","author":"Moncla","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jor.2019.05.006_bib37","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1210\/en.2007-0695","article-title":"C-type natriuretic peptide regulates cellular condensation and glycosaminoglycan synthesis during chondrogenesis","volume":"148","author":"Woods","year":"2007","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.jor.2019.05.006_bib38","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1073\/pnas.071389098","article-title":"Dwarfism and early death in mice lacking C-type natriuretic peptide","volume":"98","author":"Chusho","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jor.2019.05.006_bib39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s007740200048","article-title":"Significance of C-type natriuretic peptide (CNP) in endochondral ossification: analysis of CNP knockout mice","volume":"20","author":"Komatsu","year":"2002","journal-title":"J Bone Miner Metab"},{"issue":"5","key":"10.1016\/j.jor.2019.05.006_bib40","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10735-012-9430-2","article-title":"Implication of C-type natriuretic peptide-3 signaling in glycosaminoglycan synthesis and chondrocyte hypertrophy during TGF-\u03b21 induced chondrogenic differentiation of chicken bone marrow-derived mesenchymal stem cells","volume":"43","author":"Kocamaz","year":"2012","journal-title":"J Mol Histol"},{"key":"10.1016\/j.jor.2019.05.006_bib41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jcb.21815","article-title":"C-type natriuretic peptide regulation of limb mesenchymal chondrogenesis is accompanied by altered N-cadherin and collagen type X-related functions","volume":"105","author":"Alan","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jor.2019.05.006_bib42","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1203\/01.PDR.0000169964.66260.4B","article-title":"Amino-terminal proCNP: a putative marker of cartilage activity in postnatal growth","volume":"58","author":"Prickett","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jor.2019.05.006_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.peptides.2011.11.005","article-title":"Plasma C-type natriuretic peptide levels in healthy children","volume":"33","author":"Del Ry","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.jor.2019.05.006_bib44","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1210\/jc.2012-2598","article-title":"C-Type Natriuretic Peptide (CNP) levels are altered in boys with Klinefelter syndrome","volume":"97","author":"Olney","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.jor.2019.05.006_bib45","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1210\/jc.2007-0567","article-title":"Amino-terminal propeptide of C-type natriuretic peptide and linear growth in children: effects of puberty, testosterone, and growth hormone","volume":"92","author":"Olney","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jor.2019.05.006_bib46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1210\/jc.2007-1815","article-title":"Plasma amino-terminal pro C-type natriuretic Peptide in the neonate: relation to gestational age and postnatal linear growth","volume":"93","author":"Prickett","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"11-12","key":"10.1016\/j.jor.2019.05.006_bib47","first-page":"989","article-title":"Measurement of amino-terminal propeptide of C-type natriuretic peptide in patients with idiopathic short stature or isolated growth hormone deficiency","volume":"24","author":"Xiao","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jor.2019.05.006_bib48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/1574888X10666150202145939","article-title":"Mesenchymal stem cells and C-type natriuretic peptide signaling: a proposal for a new treatment approach for skeletal dysplasias","volume":"11","author":"Unal","year":"2016","journal-title":"Curr Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.jor.2019.05.006_bib49","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm971","article-title":"Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway","volume":"10","author":"Yasoda","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.jor.2019.05.006_bib50","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1210\/en.2008-1676","article-title":"Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias","volume":"150","author":"Yasoda","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.jor.2019.05.006_bib51","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1507\/endocrj.K10E-164","article-title":"Translational research of C-type natriuretic peptide (CNP) into skeletal dysplasias","volume":"57","author":"Yasoda","year":"2010","journal-title":"Endocr J"},{"key":"10.1016\/j.jor.2019.05.006_bib52","doi-asserted-by":"crossref","first-page":"51623","DOI":"10.1097\/MOP.0b013e32833b7a69","article-title":"Achondroplasia: pathogenesis and implications for future treatment","volume":"22","author":"Laederich","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jor.2019.05.006_bib53","unstructured":"BioMarin pharmaceutical Inc. (CA, USA), vosoritide (BMN 111) for achondroplasia, http:\/\/www.biomarin.com\/products\/pipeline\/bmn-111\/ and https:\/\/globenewswire.com\/news-release\/2015\/06\/17\/745424\/10138876\/en\/BMN-111-vosoritide-Improves-Growth-Velocity-in-Children-With-Achondroplasia-in-Phase-2-Study.html."},{"key":"10.1016\/j.jor.2019.05.006_bib54","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/art.38199","article-title":"Protective effects of C-type natriuretic peptide on linear growth and articular cartilage integrity in a mouse model of inflammatory arthritis","volume":"66","author":"B\u00fck\u00fclmez","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jor.2019.05.006_bib55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s13075-015-0747-6","article-title":"On the predictive utility of animal models of osteoarthritis","volume":"17","author":"Malfait","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 3","key":"10.1016\/j.jor.2019.05.006_bib56","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.joca.2010.07.013","article-title":"Histopathology atlas of animal model systems \u2013 overview of guiding principles","volume":"18","author":"Aigner","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"issue":"3","key":"10.1016\/j.jor.2019.05.006_bib57","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/157339708785133523","article-title":"Animal models of osteoarthritis","volume":"4","author":"Little","year":"2008","journal-title":"Curr Rheumatol Rev"},{"issue":"2","key":"10.1016\/j.jor.2019.05.006_bib58","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1208\/s12248-013-9454-x","article-title":"Animal models of osteoarthritis: challenges of model selection and analysis","volume":"15","author":"Teeple","year":"2013","journal-title":"AAPS J"},{"issue":"7","key":"10.1016\/j.jor.2019.05.006_bib59","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrrheum.2014.46","article-title":"Mouse models of osteoarthritis: modelling risk factors and assessing outcomes","volume":"10","author":"Fang","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"Suppl 3","key":"10.1016\/j.jor.2019.05.006_bib60","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.joca.2010.05.025","article-title":"The OARSI histopathology initiative \u2013 recommendations for histological assessments of osteoarthritis in the mouse","volume":"18","author":"Glasson","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"issue":"Suppl 3","key":"10.1016\/j.jor.2019.05.006_bib61","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.joca.2010.04.015","article-title":"The OARSI histopathology initiative \u2013 recommendations for histological assessments of osteoarthritis in the Guinea pig","volume":"18","author":"Kraus","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"issue":"Suppl 3","key":"10.1016\/j.jor.2019.05.006_bib62","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.joca.2010.05.029","article-title":"The OARSI histopathology initiative \u2013 recommendations for histological assessments of osteoarthritis in the rabbit","volume":"18","author":"Laverty","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.jor.2019.05.006_bib63","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.colsurfb.2014.12.038","article-title":"5-Fluorouracil delivery from metal-ion mediated molecularly imprinted cryogel discs","volume":"126","author":"\u00c7etin","year":"2015","journal-title":"Colloids Surfaces B Biointerfaces"}],"container-title":["Journal of Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972978X19300832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972978X19300832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T16:54:10Z","timestamp":1788627250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0972978X19300832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0972978X19300832"],"URL":"https:\/\/doi.org\/10.1016\/j.jor.2019.05.006","relation":{},"ISSN":["0972-978X"],"issn-type":[{"value":"0972-978X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analogs of C-type natriuretic peptide as a potential new non-surgical treatment strategy in knee osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Orthopaedics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jor.2019.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}